Skip to main content

Closed

ALLR: Allarity Therapeutics, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Operating margin-3552.8%

ROIC-43.1%

Financially safe

Stretched

Debt / equity3.11×

Interest coverage-34.3×

Current ratio1.23×

Allarity Therapeutics, Inc.

ALLRNASDAQ Global Market·USD·Closed

Allarity Therapeutics, Inc.

ALLRNASDAQ·USD·Closed

$1.21

−1.63%

$1.21

−$0.02 (1.63%)

52W Range

28thpctl

Volume

0.21×avg

Mkt Cap

19.25MUSD

P/E

-1.7TTM

Div Yield

–ann

52W Range

28thpctl

Volume

0.21×avg

Market Cap

19.25MUSD

P/E Ratio

-1.7TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings